Jacob M. Goldberg

Jacob M. Goldberg

Auto-generated profile, based on publicly available information

Jacob M. Goldberg

Department of Chemistry, Colgate University, 13 Oak Drive, Hamilton, New York 13346, United States

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2017 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
CSChanan D. Sessler
Chanan D. Sessler
MRMartin Rahm
Martin Rahm
SBSabine Becker
Sabine Becker
JGJacob M. Goldberg
Jacob M. Goldberg
FWFang Wang
Fang Wang
SLStephen J. Lippard
Stephen J. Lippard

8 December 2015 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
BKBopanna I. Kalappa
Bopanna I. Kalappa
CACharles T. Anderson
Charles T. Anderson
JGJacob M. Goldberg
Jacob M. Goldberg
SLStephen J. Lippard
Stephen J. Lippard
TTThanos Tzounopoulos
Thanos Tzounopoulos
Significance: Ionotropic glutamate AMPA receptors (AMPARs) play a fundamental role in normal function and plasticity of the brain, and they are also involved in many brain disorders. Despite the central role of AMPARs in neurobiology, the modulation of synaptic AMPA responses by endogenous modulators remains not well understood. Here, in three synapses found in two different brain areas, we provide the first evidence, to our knowledge, that endogenous zinc is coreleased with glutamate and modulates the strength of synaptic AMPAR responses. Because in many neocortical areas more than 50% of excitatory presynaptic terminals contain zinc within their glutamatergic vesicles, our findings establish zinc as a general neuromodulator that allows for fine-tuning and plasticity of glutamatergic fast synaptic transmission in the brain.

31 January 2018 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
JGJacob M. Goldberg
Jacob M. Goldberg
FWFang Wang
Fang Wang
CSChanan D. Sessler
Chanan D. Sessler
NVNathan W. Vogler
Nathan W. Vogler
DZDaniel Y. Zhang
Daniel Y. Zhang
SLStephen J. Lippard
Stephen J. Lippard

19 October 2023 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
BLBradley M. Lipka
Bradley M. Lipka
DHDaniel S. Honeycutt
Daniel S. Honeycutt
GBGregory M. Bassett
Gregory M. Bassett
TKTaylor N. Kowal
Taylor N. Kowal
MAMax Adamczyk
Max Adamczyk
FWFang Wang
Fang Wang

9 October 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
YHYu Han
Yu Han
JGJacob M. Goldberg
Jacob M. Goldberg
SLStephen J. Lippard
Stephen J. Lippard
APAmy E. Palmer
Amy E. Palmer
Small-molecule fluorescent probes are powerful and ubiquitous tools for measuring the concentration and distribution of analytes in living cells. However, accurate characterization of these analytes requires rigorous evaluation of cell-to-cell heterogeneity in fluorescence intensities and intracellular distribution of probes. In this study, we perform a parallel and systematic comparison of two small-molecule fluorescent vesicular Zn2+ probes, FluoZin-3 AM and SpiroZin2, to evaluate each probe for measurement of vesicular Zn2+ pools. Our results reveal that SpiroZin2 is a specific lysosomal vesicular Zn2+ probe and affords uniform measurement of resting Zn2+ levels at the single cell level with proper calibration. In contrast, FluoZin-3 AM produces highly variable fluorescence intensities and non-specifically localizes in the cytosol and multiple vesicular compartments. We further applied SpiroZin2 to lactating mouse mammary epithelial cells and detected a transient increase of lysosomal free Zn2+ at 24-hour after lactation hormone treatment, which implies that lysosomes play a role in the regulation of Zn2+ homeostasis during lactation. This study demonstrates the need for critical characterization of small-molecule fluorescent probes to define the concentration and localization of analytes in different cell populations, and reveals SpiroZin2 to be capable of reporting diverse perturbations to lysosomal Zn2+.

16 March 2020 in Journal of the American Chemical Society
Verified
Journal Article
Open access
MLMiseon Lee
Miseon Lee
BMBasudeb Maji
Basudeb Maji
DMDebasish Manna
Debasish Manna
SKSevim Kahraman
Sevim Kahraman
RERuth M. Elgamal
Ruth M. Elgamal
ACAmit Choudhary
Amit Choudhary
The loss of insulin-producing β-cells is the central pathological event in type 1 and 2 diabetes, which has led to efforts to identify molecules to promote β-cell proliferation, protection, and imaging. However, the lack of β-cell specificity of these molecules jeopardizes their therapeutic potential. A general platform for selective release of small-molecule cargoes in β-cells over other islet cells ex vivo or other cell-types in an organismal context will be immensely valuable in advancing diabetes research and therapeutic development. Here, we leverage the unusually high Zn(II) concentration in β-cells to develop a Zn(II)-based prodrug system to selectively and tracelessly deliver bioactive small molecules and fluorophores to β-cells. The Zn(II)-targeting mechanism enriches the inactive cargo in β-cells as compared to other pancreatic cells; importantly, Zn(II)-mediated hydrolysis triggers cargo activation. This prodrug system, with modular components that allow for fine-tuning selectivity, should enable the safer and more effective targeting of β-cells.